Literature DB >> 34012658

Prognostic value and association of sarcopenic obesity and systemic inflammatory indexes in patients with hepatocellular carcinoma following hepatectomy and the establishment of novel predictive nomograms.

Chengyu Liao1,2, Ge Li3, Yannan Bai1,2, Songqiang Zhou1,2, Long Huang1,2, Maolin Yan1,2, Funan Qiu1,2, Jiangzhi Chen3, Yaodong Wang1,2, Yifeng Tian1,2, Shi Chen1,2.   

Abstract

BACKGROUND: The specific impacts of sarcopenic obesity (SO) on hepatocellular carcinoma (HCC) and the association between SO and systemic inflammation remain unclear. This study aimed to investigate the prognostic value and association of SO and systemic inflammation with outcomes after hepatectomy for HCC and develop novel nomograms based on SO and inflammatory indexes for survival prediction.
METHODS: We retrospectively enrolled 452 patients with HCC who underwent radical hepatectomy between January 2012 and March 2015 in Fujian Provincial Hospital as the training cohort. In addition, 275 patients during the same period were enrolled as the external validation cohort. Patients were classified into different groups according to the presence of sarcopenia and obesity. Different inflammation indexes were evaluated to select the best predictor of overall survival (OS) and recurrence-free survival (RFS). Univariate and multivariate logistic regression were performed to investigate the associations between inflammatory indexes and SO. The inflammatory indexes with the highest predictive values and SO were selected for subgroup analyses to establish a novel classification system: the SOLMR grade. SOLMR grades identified in the multivariate Cox analysis were selected to construct novel nomograms for OS and RFS.
RESULTS: SO (P<0.001) was an independent risk factor for OS and RFS. The lymphocyte-monocyte ratio (LMR) had the highest areas under the receiver operating characteristic (ROC) curves (AUCs) for OS (P<0.001) and RFS (P<0.001) and was identified as an independent factor of SO (P=0.001). SO and the LMR were selected to establish the SOLMR grade. Multivariate Cox analysis revealed that SOLMR grade was a significant independent predictor of OS (P<0.001) and RFS (P<0.001). Nomograms based on SOLMR grades were generated and accurately predicted 1-, 3- and 5-year OS and RFS in HCC patients. The C-index of the novel nomograms was higher than those of the other conventional staging systems (P<0.001).
CONCLUSIONS: Both SO and the LMR were independent risk factors for OS and RFS in HCC patients after hepatectomy. The LMR was an independent factor of SO. The novel nomograms developed from the SOLMR grading system combining SO with the LMR provide good prognostic estimates of the outcomes of HCC patients. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); inflammatory indexes; nomogram; prognostic value; sarcopenia; sarcopenic obesity (SO)

Year:  2021        PMID: 34012658      PMCID: PMC8107609          DOI: 10.21037/jgo-20-341

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  45 in total

1.  Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.

Authors:  Naoto Fujiwara; Hayato Nakagawa; Yotaro Kudo; Ryosuke Tateishi; Masataka Taguri; Takeyuki Watadani; Ryo Nakagomi; Mayuko Kondo; Takuma Nakatsuka; Tatsuya Minami; Masaya Sato; Koji Uchino; Kenichiro Enooku; Yuji Kondo; Yoshinari Asaoka; Yasuo Tanaka; Kuni Ohtomo; Shuichiro Shiina; Kazuhiko Koike
Journal:  J Hepatol       Date:  2015-02-24       Impact factor: 25.083

2.  Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Shinji Itoh; Tomoharu Yoshizumi; Koichi Kimura; Hirohisa Okabe; Norifumi Harimoto; Toru Ikegami; Hideaki Uchiyama; Ken Shirabe; Akihiro Nishie; Yoshihiko Maehara
Journal:  Anticancer Res       Date:  2016-06       Impact factor: 2.480

3.  Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib.

Authors:  Atsushi Hiraoka; Masashi Hirooka; Yohei Koizumi; Hirofumi Izumoto; Hidetaro Ueki; Miho Kaneto; Shogo Kitahata; Toshihiko Aibiki; Hideomi Tomida; Yuji Miyamoto; Hiroka Yamago; Yoshifumi Suga; Ryuichiro Iwasaki; Kenichiro Mori; Hideki Miyata; Eiji Tsubouchi; Masato Kishida; Tomoyuki Ninomiya; Masanori Abe; Bunzo Matsuura; Hideki Kawasaki; Yoichi Hiasa; Kojiro Michitaka
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

4.  Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.

Authors:  Bo Hu; Xin-Rong Yang; Yang Xu; Yun-Fan Sun; Chao Sun; Wei Guo; Xin Zhang; Wei-Min Wang; Shuang-Jian Qiu; Jian Zhou; Jia Fan
Journal:  Clin Cancer Res       Date:  2014-09-30       Impact factor: 12.531

5.  Sarcopenia and American Society of Anesthesiologists Physical Status in the Assessment of Outcomes of Hepatocellular Carcinoma Patients Undergoing Hepatectomy.

Authors:  Kosei Takagi; Takahito Yagi; Ryuichi Yoshida; Susumu Shinoura; Yuzo Umeda; Daisuke Nobuoka; Takashi Kuise; Nobuyuki Watanabe; Toshiyoshi Fujiwara
Journal:  Acta Med Okayama       Date:  2016-10       Impact factor: 0.892

6.  Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies.

Authors:  Rebecca M Dodson; Amin Firoozmand; Omar Hyder; Vania Tacher; David P Cosgrove; Nikhil Bhagat; Joseph M Herman; Christopher L Wolfgang; Jean-Francois H Geschwind; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-09-25       Impact factor: 3.452

7.  Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.

Authors:  Judith Meza-Junco; Aldo J Montano-Loza; Vickie E Baracos; Carla M M Prado; Vincent G Bain; Crystal Beaumont; Nina Esfandiari; Jessica R Lieffers; Michael B Sawyer
Journal:  J Clin Gastroenterol       Date:  2013 Nov-Dec       Impact factor: 3.062

Review 8.  Sarcopenic obesity.

Authors:  Stergios A Polyzos; Andrew N Margioris
Journal:  Hormones (Athens)       Date:  2018-07-16       Impact factor: 2.885

Review 9.  Association between Loss of Skeletal Muscle Mass and Mortality and Tumor Recurrence in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ke-Vin Chang; Jin-De Chen; Wei-Ting Wu; Kuo-Chin Huang; Chia-Tzu Hsu; Der-Sheng Han
Journal:  Liver Cancer       Date:  2017-12-09       Impact factor: 11.740

Review 10.  Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery?

Authors:  Kimberly L Mei; John A Batsis; Jeannine B Mills; Stefan D Holubar
Journal:  Perioper Med (Lond)       Date:  2016-10-26
View more
  4 in total

1.  Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.

Authors:  Yuki Yamada; Yoshihisa Shimada; Yojiro Makino; Yujin Kudo; Sachio Maehara; Takafumi Yamada; Masaru Hagiwara; Masatoshi Kakihana; Tatsuo Ohira; Norihiko Ikeda
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-02       Impact factor: 4.322

2.  Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis.

Authors:  Giovanni Marasco; Elton Dajti; Matteo Serenari; Luigina Vanessa Alemanni; Federico Ravaioli; Matteo Ravaioli; Amanda Vestito; Giulio Vara; Davide Festi; Rita Golfieri; Matteo Cescon; Matteo Renzulli; Antonio Colecchia
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.575

3.  Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score.

Authors:  Yongjiang Li; Yangxun Pan; Ximeng Lin; Jingyu Hou; Zili Hu; Li Xu; Zhongguo Zhou; Yaojun Zhang; Minshan Chen; Dandan Hu
Journal:  Front Pharmacol       Date:  2022-02-08       Impact factor: 5.810

Review 4.  Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease.

Authors:  Vittoria Zambon Azevedo; Cristina Alina Silaghi; Thomas Maurel; Horatiu Silaghi; Vlad Ratziu; Raluca Pais
Journal:  Front Nutr       Date:  2022-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.